Rep. Rick W. Allen sells $15K–$50K of Abbott Laboratories (ABT) while on a related committee
Rep. Rick W. Allen (R-GA) reported a sale of ABT worth $15K–$50K.
Rep. Rick W. Allen (R-GA) reported that their spouse sold Abbott Laboratories (ABT) stock worth $15K–$50K on July 14, 2026. The trade was disclosed in a Periodic Transaction Report filed on August 18, 2026, 35 days after the trade.
Allen sits on the House Committee on Energy and Commerce, whose work touches health care, an area that matters to Abbott Laboratories.
In the year before, Allen reported 1 other trade in ABT: 0 purchases and 1 sale.
Across all their reports we have read, Rick W. Allen disclosed 36 stock trades.
The law gives only a range for each trade, so the exact amount and price are not public.
What happened next: since the week of the sale, ABT has risen 13.5%. A fall after a sale means the sale came before a drop.
Source: Periodic Transaction Report ↗. Written automatically from the report and weekly price data. Information, not investment advice. Published free for the public; congressional disclosure reports may not be used for commercial purposes or soliciting money.
Examples
In 2020 several senators faced questions over stock sales made after private briefings on the coronavirus. Those trades became public through the same kind of report this story is built from.
Explain it like I'm 13
Members of Congress write the rules for many companies, so the law makes them tell the public when they buy or sell stocks. This report is like a referee saying which team's merchandise they bought: it does not mean they did anything wrong, but it lets everyone check.